Poll: What Minimum Educational Requirement Should Infection Preventionists Have?

GigaGen, a biotech company, secures an $11.8M contract expansion with the US Department of Defense to develop synthetic human antibody treatments for botulinum neurotoxins.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 25, 2023.

For Thanksgiving, Infection Control Today® asked its Editorial Advisory Board what they're thankful for. From family to dreams coming true, they express gratitude for various aspects of life and work.

Marking the World Health Organization's World AMR Awareness Week, “Going Blue: Confronting the AMR Challenge,” urges health care providers and the public to educate, follow protocols, and ensure patient safety for antibiotic efficacy.

Mass General Brigham and Salem Hospital face a class action lawsuit over potential hepatitis and HIV exposure to hundreds of patients. The lawsuit alleges negligence and emotional distress, with the hospital claiming a minimal infection risk.

Prepare for a healthcare "tripledemic" with Influenza, RSV, and COVID-19. Operating rooms face risks, but autonomous UV disinfection systems offer an effective solution to maintain sterility.